These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37930191)

  • 1. Macrocyclic-Albumin Conjugates for Precise Delivery of Radionuclides and Anticancer Drugs to Tumors.
    Li S; Wang Y; Wang X; Feng J; Guo DS; Meng Z; Liu Y; Sun SK; Zhang Z
    ACS Nano; 2023 Nov; 17(22):22399-22409. PubMed ID: 37930191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calixarene-modified albumin for stoichiometric delivery of multiple drugs in combination-chemotherapy.
    Wang Y; Zhang Z; Zhao X; Xu L; Zheng Y; Li HB; Guo DS; Shi L; Liu Y
    Theranostics; 2022; 12(8):3747-3757. PubMed ID: 35664058
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrocyclic-Amphiphile-Based Self-Assembled Nanoparticles for Ratiometric Delivery of Therapeutic Combinations to Tumors.
    Zhang Z; Yue YX; Xu L; Wang Y; Geng WC; Li JJ; Kong XL; Zhao X; Zheng Y; Zhao Y; Shi L; Guo DS; Liu Y
    Adv Mater; 2021 Mar; 33(12):e2007719. PubMed ID: 33598992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy.
    Châtre R; Lange J; Péraudeau E; Poinot P; Lerondel S; Le Pape A; Clarhaut J; Renoux B; Papot S
    J Control Release; 2020 Nov; 327():19-25. PubMed ID: 32777236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codelivery of π-π Stacked Dual Anticancer Drugs Based on Aloe-Derived Nanovesicles for Breast Cancer Therapy.
    Zeng L; Shi W; Wang H; Cheng X; Chen T; Wang LL; Lan J; Sun W; Liu M; Zhang X; Zhang J; Chen J
    ACS Appl Mater Interfaces; 2022 Jun; 14(24):27686-27702. PubMed ID: 35675505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-Responsive Codelivery System Self-Assembled from
    Wu X; Zhang D; Pan T; Li J; Xie Y; Zhang C; Pan C; Zhang Z; Lin J; Wu A; Shao G
    ACS Appl Mater Interfaces; 2023 Sep; 15(38):44773-44785. PubMed ID: 37721368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-binding prodrugs via reversible iminoboronate forming nanoparticles for cancer drug delivery.
    Hao L; Zhou Q; Piao Y; Zhou Z; Tang J; Shen Y
    J Control Release; 2021 Feb; 330():362-371. PubMed ID: 33359484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges.
    Kandra P; Kalangi HP
    Appl Microbiol Biotechnol; 2015 Mar; 99(5):2055-64. PubMed ID: 25698508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Antitumor Dual-Responsive Host-Guest Supramolecular Polymer Based on Hypoxia-Cleavable Azocalix[4]arene.
    Yao SY; Yue YX; Ying AK; Hu XY; Li HB; Cai K; Guo DS
    Angew Chem Int Ed Engl; 2023 Jan; 62(2):e202213578. PubMed ID: 36353747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy.
    Yu F; Tu Y; Luo S; Xiao X; Yao W; Jiang M; Jiang X; Yang R; Yuan Y
    Nano Lett; 2021 Mar; 21(5):2216-2223. PubMed ID: 33635657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.
    Liu J; Zhang N; Wu J; Dong P; Lv H; Wang Q; Wang S; Yang H; Wang S; Li X; Hu J; Wang A; Li DJ; Shi Y
    Int J Nanomedicine; 2022; 17():4895-4910. PubMed ID: 36262192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the fatty acid chain length on in vitro and in vivo anticancer activity of fattigation-platform albumin nanoparticles in human colorectal cancer xenograft mice model.
    Park C; Baek N; Loebenberg R; Lee BJ
    J Control Release; 2020 Aug; 324():55-68. PubMed ID: 32380202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy.
    Liu X; Mohanty RP; Maier EY; Peng X; Wulfe S; Looney AP; Aung KL; Ghosh D
    J Control Release; 2020 Dec; 328():1-12. PubMed ID: 32798638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.
    Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X
    Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers.
    Yi X; Lian X; Dong J; Wan Z; Xia C; Song X; Fu Y; Gong T; Zhang Z
    Mol Pharm; 2015 Nov; 12(11):4085-98. PubMed ID: 26422373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
    Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
    Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
    Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
    Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.